-
Assessing the Feasibility of Using an Electronic Platform for Personalized Outcome Assessment: GoalNav for Goal Attainment Scaling
Mar 10, 2025, 14:00 PM -
Temporal Trends in Prescription of GLP-1RAs for Weight Loss: Insights From a Five-Year Retrospective Analysis in the US
Mar 10, 2025, 14:00 PM -
Economic Burden of Lung Cancer from the Perspective of a Brazilian Public Hospital
Mar 10, 2025, 14:00 PM -
Cost-Utility Analysis of Dupilumab Versus Omalizumab in the Treatment of Severe Asthma in China
Mar 10, 2025, 14:00 PM -
Health Care Resource Utilization (HCRU), and Direct Medical Costs Among Patients With Locally Advanced or Metastatic HER2 Negative Gastric Cancer (GC) in the United States.
Mar 10, 2025, 14:00 PM -
A Retrospective Cohort Study Evaluating the Association Between Fibrosis-4 Index and Major Adverse Cardiovascular Events in Patients with Metabolic Dysfunction-Associated Steatohepatitis
Mar 10, 2025, 14:00 PM -
Non-Invasive Tests (NITs) to Risk-Stratify Patients with Noncirrhotic Metabolic-Associated Steatohepatitis (MASH) in a Specialty Setting Eligible for Resmetirom: A Cost-Effectiveness Analysis from a U.S. Payer Perspective
Mar 10, 2025, 14:00 PM -
Real-Time Technology Adoption: Assessing Early Real-World Trends in Renal Denervation Therapy Following Initial Device Approval
Mar 10, 2025, 14:00 PM -
Artificial Intelligence Software as a Medical Device: Regulatory Approvals and Post-Deployment Evaluation Frameworks in North America and Europe
Mar 10, 2025, 14:00 PM -
Development and Psychometric Validation of Patient-Reported Outcome Measures for Masseter Muscle Prominence (MMP): The Lower Facial Shape Questionnaire
Mar 10, 2025, 14:00 PM -
Assessing the Impact of Frailty on Healthcare Burden Post-Surgery in Head and Neck Cancer Patients
Mar 10, 2025, 14:00 PM -
Real-World Study Evaluating Drug Tolerability and Health Care Resource Use (HCRU) With Acalabrutinib vs Ibrutinib in Patients With Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
Mar 10, 2025, 14:00 PM -
Study of Patient Preferences Regarding a New Class of Antihypertensive Medications: A Discrete Choice Experiment in Ukraine
Mar 10, 2025, 14:00 PM -
Retrospective Databases in Health Outcomes, Pharmacoepidemiology, and Pharmacy Practice Research
Mar 10, 2025, 14:00 PM -
Adoption of a Drug Adherence-Enhancing Application To Achieve Optimal Medication Adherence and Blood Pressure Control Among Hypertensive Patients: A Randomized Controlled Trial
Mar 10, 2025, 14:00 PM -
Development of a Conceptual Model Supporting a Clinical Outcome Assessment Strategy for Acquired Angioedema Due to C1 Inhibitor Deficiency
Mar 10, 2025, 14:00 PM -
Assessing Overall Survival and Treatment Impact in Progressive Multifocal Leukoencephalopathy
Mar 10, 2025, 14:00 PM -
A Retrospective Analysis of the Italian Medicines Agency’s Evaluation of Real-World Evidence in Innovativeness Assessments
Mar 10, 2025, 14:00 PM -
Moving the Needle: Value and Use of Real-World Evidence in Oncology Clinical Pathways Decision-Making
Mar 10, 2025, 14:00 PM -
Cost-Effectiveness Analysis of Tripalimumab for Metastatic or Recurrent Triple-Negative Breast Cancer in Japan
Mar 10, 2025, 14:00 PM
